Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines
Anthony Myint, Myron J. Tong, Simon W. Beaven – 7 May 2020
Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention
Evelyn F. Miller – 7 May 2020
Integrating Palliative Care in the Management of Patients With Advanced Liver Disease
Arpan Patel, Nneka N. Ufere – 7 May 2020
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Ann Robinson, Robert J. Wong – 7 May 2020
Letter to the Editor: Issues of Circular RNAs as MicroRNA Sponges
Yezhao Wang – 7 May 2020
Is There Evidence of the Hawthorne Effect in Quality Improvement of Nutritional Consultation in Inpatients With Cirrhosis?
Jawaid Shaw, Jasmohan S. Bajaj – 7 May 2020
Evolution of Systemic Therapy for Hepatocellular Carcinoma
Richard S. Finn, Andrew X. Zhu – 7 May 2020 – Despite being one of the leading causes of cancer death globally, hepatocellular carcinoma (HCC) has historically not been the focus of novel drug development. That has changed in the past several years, with the results from a number of hallmark phase 3 studies in advanced HCC. In HCC, immune‐oncology approaches have garnered much attention; there is still a need to better understand criteria for patient selection and to optimize combination strategies to maximize the potential of these approaches.
Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Ann Robinson, Robert J. Wong – 7 May 2020
Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines
Anthony Myint, Myron J. Tong, Simon W. Beaven – 7 May 2020
A Big Step Forward in Hepatitis C Screening
Nikhil Kapila, Andrew J. Muir – 7 May 2020